Abstract
This study was designed to determine whether zerumbone, an essential bioactive compound isolated from Zingiber zerumbet Smith protects against early ethanol induced liver injury in rats. Male Sprague-Dawley rats were administered with 0.05% (v/v) to 0.5% (v/v) of zerumbone for 14 days. Following the final dosage of zerumbone, the animals were administered with 50% (v/v) ethanol for 14 days. We have observed that pre-treatment of zerumbone had suppressed fatty liver formation following ethanol 50% (v/v) administration. Meanwhile, rats that were treated with ethanol only, found to show significant level of focal vacuolated fatty liver with focal necrosis in the mid zonal region. Therefore, fatty liver development was found to be extensively reduced in animals that were pretreated with zerumbone.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
